Predictive biomarker of cetuximab res...

Predictive biomarker of cetuximab response incolorectal cancer patients

Posted in the Oncology Forum

Sciclips

Madison, WI

#1 Feb 22, 2012
According to a recent US patent application, serum YKL-40 can be a prognostic biomarker for predicting short overall survival in patients with metastatic colorectal cancer treated with cetuximab. Details: http://www.sciclips.com/sciclips/biomarker-ne...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Lehigh Valley Children's Hospital opens final a... Jul 20 weaponX 1
News Can the Sunshine Vitamin Help Lymphoma Patients? Jul 20 duh 1
News Psychological intervention reduces fear of recu... Jun '17 Humanspirit 1
News Vaccine may cut HPV infections, an oral cancer ... May '17 HPV conjob 1
News Parker Hughes Cancer center suspending operations (Feb '08) Apr '17 Laura 17
Benign tumor Mar '17 Bharath k 1
News Myriad Genetics Announces an Assay that Identif... (Nov '16) Feb '17 Purplemouse2 8
More from around the web